Oaktree Acquisition Corp. III Life Sciences
corporate_fare Company Profile
Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 7 items for OACC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 7 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for OACC spans 10-Q, 8-K, DEF 14A, PRE 14A.
Recent high-impact activity:
- Oaktree SPAC III Posts $452,553 Q3 Loss; Trust Shrinks to ~$85M After 59% Redemption
- Oaktree SPAC III Wins Extension to May 2027; 11.3M Shares Redeemed for $122.4M
- Oaktree SPAC III: 13.3M Shares Redeemed Ahead of Oct 16 Extension Vote
- Oaktree SPAC Sets October 16 Vote to Extend Business Combination Deadline to May 2027
- SPAC Seeks 7-Month Extension to Avoid Liquidation as Deadline Looms
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 1,324 shares in OACC as of the October 30, 2026 settlement, a 586.0% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 1.0% of OACC volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.